JP Morgan resumed coverage on PACS Group with a new price target
$PACS
Hospital/Nursing Management
Health Care
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/6/2024 | $40.00 | Overweight | JP Morgan |
| 10/9/2024 | $50.00 | Buy | UBS |
| 9/11/2024 | $45.00 | Buy | Citigroup |
| 6/28/2024 | $35.00 | Outperform | Macquarie |
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=ngVWINHF or by dialing 877-407-0621 / +1 215-268-9899. A recording of the call will be available for replay via the website for
PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806841957/en/PACS headquarters in Farmington, Utah. (Photo: Business Wire) PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://IR.pacs.com, or https://e
8-K - PACS Group, Inc. (0002001184) (Filer)
NT 10-Q - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00
Citigroup resumed coverage of PACS Group with a rating of Buy and set a new price target of $45.00
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $32 to $36.
In the preceding three months, 11 analysts have released ratings for PACS Group (NYSE:PACS), presenting a wide array of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 8 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 7 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $31.36, a high estimate of $35.00, and a low estimate of $27.00. Observing
Macquarie analyst Tao Qiu initiates coverage on PACS Group (NYSE:PACS) with a Outperform rating and announces Price Target of $35.
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)
SC 13G - PACS Group, Inc. (0002001184) (Subject)
PACS Group, Inc. (NYSE:PACS) ("PACS") is proud to announce that 36 of its affiliated post-acute communities have been named by U.S. News & World Report to their list of Best Nursing Homes for 2025. Those communities are as follows: Community Name Location All Saints Maubert San Leandro, CA All Saints Subacute & Transitional Care San Leandro, CA Balboa Nursing & Rehabilitation Center San Diego, CA Bel Vista Healthcare Center Long Beach, CA Brushy Creek Post Acute Greer, SC Canyon Vista Post Acute Las Vegas, NV Central Gardens Post Acute San Francisco, CA Citrus Heights Post Acute
PACS Group, Inc. (NYSE:PACS) ("PACS") is proud to announce that 17 of its post acute communities have been named by Newsweek Magazine to their Best Nursing Homes for 2025. Those communities are as follows, listed in order by their state, and then their ranking in their state by category: Community Name State Ranking Category Apache Junction Health Center Arizona Fifth Over 150 beds Ridgecrest Post Acute Arizona Eighth Over 150 beds Escondido Post Acute California 15th Over 150 beds Rossmoor Post Acute California 17th Over 150 beds
Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op